Relief Therapeutics Holding AG (RLFTF)

[mc67]

$RLFTF (related) NeuroRX on LinkedIN

"The Republic of Georgia's Minister of Health today initiated an expanded access program to treat critically ill patients with COVID-19 respiratory failure with ZYESAMI. NeuroRx was invited to extend its industry partnership with the Republic of Georgia under the auspices of the Richard Lugar Institute for Public Health Research and the National Security Health Policy Center of the Potomac Institute for Policy Studies, in light of the company's partnership with the U.S. NIH. As the world confronts ongoing waves of infection and new variants, NeuroRx is anxious to share ZYESAMI, a proven, lifesaving therapeutic, with critically ill COVID-19 patients in Georgia, the Caucasus region and beyond. Learn more about the partnership: LINK IN REPLY"